Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain

Cochrane Reviews

Hormone therapy for sexual function in perimenopausal and postmenopausal women

Cochrane Systematic Reviews

Nastri CO, Lara LA, Ferriani RA, Rosa-e-Silva AJS, Figueiredo JBP, Martins WP

This review aimed to assess the effect of hormonal therapy (HT), specifically estrogens alone, estrogens in combination with progestogens, synthetic steroids, and SERMs, on sexual function in perimenopausal and postmenopausal women.

The authors concluded that HT treatment with estrogens alone or in combination with progestogens is associated with a small to moderate improvement in sexual function when used specifically in women with menopausal symptoms or who were in early postmenopause (within five years after onset of menopause), but not when used for any postmenopausal woman.

Evidence regarding other HTs (tibolone, raloxifene, and bazedoxifene) is of low quality.

The current evidence does not suggest an important effect of tibolone, raloxifene and bazedoxifene, alone or combined with estrogens, on sexual function.

http://summaries.cochrane.org/CD009672/hormonal-therapy-for-sexual-function-in-menopausal-women 

This version first published online: 5 June 2013

Content Updated 5 June 2013 

PrintEmail

Search

Facebook Follow AMS on Linkedin Follow us on Twitter @amsCoolAgain